Matriptase: a culprit in cancer? (Q37401353)

20 August 2017

1 reference

title

Matriptase: a culprit in cancer? (English)

1 reference

20 August 2017

Karin List

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Future Oncology

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

97-104

1 reference

Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Type II transmembrane serine proteases in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Characterization of matriptase expression in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Autosomal recessive ichthyosis with hypotrichosis syndrome: further delineation of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Live imaging of chronic inflammation caused by mutation of zebrafish Hai1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

MT-SP1 proteolysis and regulation of cell-microenvironment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Biochemical characterization of prostasin, a channel activating protease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

The epidermal barrier function is dependent on the serine protease CAP1/Prss8

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Gene expression profiling identifies matriptase overexpression in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

The novel serine protease tumor‐associated differentially expressed gene–15 (matriptase/MT‐SP1) is highly overexpressed in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

Gene silencing in a human organotypic skin model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.5.1.97

21 January 2018

Identifiers

DOI

10.2217/14796694.5.1.97

1 reference

20 August 2017

1 reference